Philips Installs State-of-the-Art Hybrid Operating Room at Leading Russian Medical Institute in Moscow

Royal Philips ElectronicsThe Russian Cardiology Research and Production Complex and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the opening of an innovative new hybrid operating room equipped with advanced live image guidance solutions to guide minimally-invasive cardiovascular and endovascular procedures. This new hybrid operating room, which also features other Philips technology innovations, is the first of its kind in Russia.

As surgical procedures continue to evolve from open surgery to minimally-invasive procedures, surgeons require a single hybrid operating room solution that meets the needs of both types of surgery. The new hybrid operating room at the Federal Russian Cardiology Research and Production Complex is equipped with Philips' latest interventional tools, such as its Allura Xper FD20 system with FlexMove for easy access to high resolution imaging and its HeartNavigator navigation tool, to support a wide range of minimally-invasive procedures. These include the repair of restrictions (stenoses) or ballooning (aneurysms) in arteries or veins, and minimally-invasive heart valve replacement (Transcatheter Aortic Valve Implantation (TAVI)).

"A hybrid intervention in cardiac surgery is associated with minimal patient trauma and gives positive results in 95% to 97% of the procedures," says Renat S. Akchurin, academician, associate professor of cardiovascular surgery and honorary Member of the Russian Academy of Sciences and Medical Sciences (RAS & RAMS). "The results are really impressive. Patients recover quickly and leave the hospital after a relatively short period of time."

The Russian Cardiology Research and Production Complex is a federal institute and is Russia's leading national clinical and research institute for applied and fundamental cardiology. It leads the coordination of Russia's national research programs in the field of cardiovascular diseases.

After the opening ceremony for the new hybrid operating room, Renat S. Akchurin and Karl E. Hauptmann MD, Chief of the Cardiology Division at the Hospital of Barmherzigen Brüder (Trier, Germany), are performing TAVI and EVAR (Endovascular Aneurysm Repair) procedures that will be webcast live in both the Russian and English languages via www.philips.ru/live. The webcast starts at 08:20 AM CET.

Participants will have the opportunity to ask questions and listen to answers online during the procedure. This will allow healthcare professionals and laypeople worldwide to learn more about new methods of treatment and new technologies for imaging and cardiac surgery.

"Philips is dedicated to creating the future of healthcare by delivering innovative solutions that address major healthcare challenges, such as the rise of cardiovascular disease," says Arjan de Jongste, Market Leader Philips Russia and Central Asia. "Because of the benefits to patients and care providers of image-guided minimally invasive treatments, such as greater patient comfort, shorter recovery periods, and faster patient throughput, it is a fast growing field of medicine and a key area of innovation for Philips."

Philips equipment installed in the hybrid operating room at this renowned Russian cardiology center also simplifies the workflow. Philips has installed its ceiling-mounted FlexMove option, allowing the Allura Xper FD 20 interventional X-ray imaging system to be moved both laterally and longitudinally in order to guarantee optimal access to the patient throughout procedures. Moreover, live 3D image guidance tools provide extra support for TAVI procedures: Philips HeartNavigator is an innovative procedure planning and image guidance tool to help interventional cardiologists and cardiac surgeons perform such procedures. The tool merges pre-operatively acquired 3D CT scans of the patient's heart with the live interventional X-ray views. Using this technology, physicians can now simultaneously see the detailed 3D anatomy of the patient's heart together with the positioning of the catheter and the placement and deployment of the artificial valve.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...